Subtypes of immunoglobulin (Ig)-G antibodies against donor class II HLA and cross-match results in three kidney transplant candidates

Transplant Immunology

Volumn 23, Issue 1-2, 2010, Pages 81-85

  Lobashevsky, A ^a,b   Rosner, K ^a   Goggins, W ^b   Higgins, N ^a  

^a INDIANA UNIVERSITY HEALTH   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Antibodies; Cross match; HLA; IgG subtypes; Luminex

Indexed keywords

HLA A ANTIGEN; HLA ANTIBODY; HLA B ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G4; HLA D ANTIGEN; IMMUNOGLOBULIN G;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DESENSITIZATION; FLOW CYTOMETRY; GRAFT RECIPIENT; HLA SYSTEM; HLA TYPING; HUMAN; HUMAN CELL; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; BLOOD GROUP TYPING; GRAFT REJECTION; IMMUNOLOGY; PROCEDURES;

B-LYMPHOCYTES; BLOOD GROUPING AND CROSSMATCHING; GRAFT REJECTION; HLA-D ANTIGENS; HUMANS; IMMUNOGLOBULIN G; KIDNEY TRANSPLANTATION;

EID: 77953812538     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2010.03.003     Document Type: Article

References (19)

1. Cornell L.D., Smith R.N., Colvin R.B. Kidney transplantation: mechanisms of rejection and acceptance. Annu Rev Pathol 2008, 3(2):189-220.
2. Gebel H.M., Moussa O., Eckels D.D., Bray R.A. Donor-reactive HLA antibodies in renal allograft recipients: considerations, complications, and conundrums. Hum Immunol 2009, 70(8):610-617.
3. Scornik J.C., LeFor W.M., Cicciarelli J.C., Brunson M.E., Bogaard T., Howard R.J., et al. Hyperacute and acute kidney graft rejection due to antibodies against B cells. Transplantation 1992, 54(1):61-64.
4. Tambur A.R., Bray R.A., Takemoto S.K., Mancini M., Costanzo M.R., Kobashigawa J.A., et al. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection. Transplantation 2000, 70(7):1055-1059.
5. Vlad G., Ho E.K., Vasilescu E.R., Colovai A.I., Stokes M.B., Markowitz G.S., et al. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival. Hum Immunol 2009, 70(8):589-594.
6. Warner P. Nebulous humors: defining alloantibodies in the 21st century. Hum Immunol 2009, 70(8):623-626.
7. Lobashevsky A.L., Manwaring J.E., Travis M.M., Nord B.L., Higgins N.G., Serov Y.A., et al. Effect of desensitization in solid organ transplant recipients depends on some cytokines genes polymorphism. Transpl Immunol 2009, 21(3):169-178.
8. Vincent A., Venetz J.-P., Pantaleo G., Pascual M. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant. Hum Immunol 2009, 70(8):580-583.
9. Heinemann F.M., Roth I., Rebmann V., Arnold M.L., Witzke O., Wilde B., et al. Immunoglobulin isotype-specific characterization of anti-human leukocyte antigen antibodies eluted from explanted renal allografts. Hum Immunol 2007, 68(6):500-506.
10. Lobashevsky A.L., Senkbeil R.W., Shoaf J., Mink C., Rowe C., Burke R., et al. Specificity of preformed alloantibodies causing B cell positive flow crossmatch in renal transplantation. Clin Transplant 2000, 14(6):533-542.
11. Böhmig G.A., Bartel G., Wahrmann M. Antibodies, isotypes and complement in allograft rejection. Curr Opin Organ Transplant 2008, 13(4):411-418.
12. Vaidya S., Cooper T.Y., Avandsalehi J. Improved flow cytometric detection of HLA alloantibodies using pronase: potential implications in renal transplantation. Transplantation 2001, 71(3):422-428.
13. Kosmoliaptsis V., Bradley J.A., Peacock S., Chaudhry A.N., Taylor C.J. Detection of immunoglobulin G human leukocyte antigen-specific alloantibodies in renal transplant patients using single-antigen-beads is compromised by the presence of immunoglobulin M human leukocyte antigen-specific alloantibodies. Transplantation 2009, 87(6):813-820.
14. Stastny P., Ring S., Lu C., Arenas J., Han M., Lavingia B. Role of immunoglobulin (Ig)-G and IgM antibodies against donor human leukocyte antigens in organ transplant recipients. Hum Immunol 2009, 70(8):600-604.
15. Saw C.L., Bray R.A., Gebel H.M. Cytotoxicity and antibody binding by flow cytometry: a single assay to simultaneously assess two parameters. Cytometry B Clin Cytom 2008, 74(5):287-294.
16. Al-Lamki R.S., Bradley J.R., Pober J. Endothelial cells in allograft rejection. Transplantation 2008, 86(10):1340-1348.
17. Jindra PT Zhang X., Mulder A., Claas F., Veale J., Jin YP Reed E.F. Anti-HLA antibodies can induce endothelial cell survival or proliferation depending on their concentration. Transplantation 2006, 82(Suppl.1):S33-S35.
18. Murata K., Baldwin W.M. Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection. Transplant Rev (Orlando) 2009, 23(3):139-150.
19. Fuller A., Profaizer T., Roberts L., Fuller T.C. Repeat donor HLA-DR mismatches in renal transplantation: is the increased failure rate caused by noncytotoxic HLA-DR alloantibodies?. Transplantation 1999, 68(45):589-591.